Contact person

David Munis Zepernick

David Munis Zepernick

Head of Business Development and Public Affairs

Previous events

MVA Event
06 Feb 2020
9:00 - 14:30 / Medicon Valley Alliance, Copenhagen

Do you have a strategy for building analytic excellence in your organization?   Your competitors do. Organizations that take an enterprise approach to analytics outperform their competition. By making analytics the cornerstone of problem solving and decision making in every facet of business, you’ll generate more insights, accelerate innovation and create value.  Maybe you work in an […]

Read more
MVA Event
25 Sep 2019
11:00 - 15:00 / Medicon Valley Alliance, Copenhagen S

The future of pharmaceutical manufacturing is digital For the highly-regulated life sciences and food & beverage industries, Industry 4.0 represents a unique challenge. There is no doubt that the future of all manufacturing is digital. Yet, how do we get there? What is the best approach and how can companies ensure that they follow an […]

Read more
MVA Event
23 Jan 2019
9:00 - 12:00 / Medicon Valley Alliance, Copenhagen S

Welcome to our Boost Seminar! On the 23rd January 2019 we invite you and your colleagues in the development & regulatory departments to a complimentary seminar on how to fully leverage on oral explanations and other opportunities to convince EU regulators. There are many opportunities for bringing your message across to regulators, by interacting with […]

Read more
MVA Event
06 Dec 2017
8:30 - 13:00 / Medicon Valley Alliance, Copenhagen S

We are pleased to invite you to our Boost Seminar on the topic Navigating the Shifting Currents of U.S. Biotech and Pharmaceutical Patent Law with King & Spalding. United States patent law is in flux.  Restriction in subject matter eligibility, initial experience with biosimilar patent litigation, application of the new prior art definitions, and recent developments […]

Read more
MVA Event
23 May 2017
10:00 - 13:30 / Medicon Village, Lund

We are pleased to invite you to a half-day seminar where you will learn how to facilitate trial safety and efficacy with automated reporting tools, roll-based workflows and clinical analysis capabilities including risk-based monitoring, data monitoring and fraud detection. Date: Tuesday May 23rd, 2017 Time: 10:00 – 13:30 Venue: Medicon Village, Scheelevägen 2, 223 63 Lund, Sweden – […]

Read more
MVA Event
21 Mar 2013
09:00 to 16:00 / Ørestad, Denmark

Building on the success from April’s seminar, Medicon Valley Alliance in cooperation with DNB invites you to participate in a second network meeting on how to attract investors and industry partners to a life science company. At the meeting you will also have the opportunity to present your technology / business plan to any of the…

Read more
MVA Event
25 Oct 2012
16:00 to 18:30 /

Medicon Valley Alliance in collaboration with ICON plc invites you to join leading industry experts on biomarker research for a unique, dynamic and interactive evening. Science after Hours is a “moving round table” networking event where you can learn and engage with leading biomarker experts and industry colleagues about compelling scientific insights on the use […]

Read more
MVA Event
21 Sep 2012
08:30 to 13:00 /

The Nordic arena for early clinical trials attracts pharmaceutical companies from all over the world. What they seek is high quality trials performed by high performing sites. What can the Nordic countries provide and how can companies within the Medicon Valley make best use of the expertise available right on our doorstep? This seminar aims […]

Read more
MVA Event
17 Apr 2012
09:00 to 16:00 /

17 April 2012 / Ørestad / Denmark Medicon Valley Alliance in cooperation with DNB invites you to participate in a network meeting on how to attract investors and industry partners to a life science company. At the meeting you will also have the opportunity to present you technology / business plan to any of the […]

Read more
MVA Event
28 Feb 2012
10:00 to 15:00 /

This seminar will address several of today’s key challenges in drug development leading up to clinical proof of concept. The agenda brings together a panel of speakers from academia, pharmaceutical companies and solution providers to discuss key issues from formulation design right through to effective clinical trial planning. The final session w ill discuss how […]

Read more
MVA Event
27 Feb 2012
08:30 to 13:00 /

Organotypic 3D-cell-culture systems are implemented at various stages in the compound development process for de-risking new drug candidates and can provide a wealth of meaningful efficacy and toxicology data. A growing list of publications confirms the striking similarities of these systems to in vivo tissue, clearly underlining their high potential value to the pharmaceutical industry. […]

Read more